It is no longer regarded as a subtype of PTC; instead, it has been established that this tumor, often diagnosed in individuals with familial adenomatous polyposis (FAP), is not associated with BRAF V600E or RAS mutations, but rather APC mutations. This evidence concerns the gene BRAF and Familial adenomatous polyposis.